Welcome to The Times of Israel’s Daily Briefing, your 15-minute audio update on what’s happening in Israel, the Middle East, and the Jewish world, from Sunday through Thursday.
Health reporter Nathan Jeffay and New York-based news editor Luke Tress join Amanda Borschel-Dan for a packed, diverse program.
Jeffay starts us off right with some optimistic news about the waning Omicron coronavirus wave. We hear about the efficacy of vaccines on pregnant women and their babies after birth. We also learn about a new Omicron-targeted vaccine that is getting an Israeli trial.
Think you may have had COVID but aren’t really sure? A new study out of Tel Aviv’s Ichilov Hospital indicates you probably weren’t infected.
We then turn to Tress and hear about the fascinating case of a proliferation of Yiddish-language New Testaments being delivered in ultra-Orthodox Jewish communities in New York. Who is behind this and why is it upsetting to some?
Tress then sheds light on an unusual location for a new Chabad house — the metaverse. What exactly is going on here?
And finally, we end the program with more medical good news. Jeffay spotlights a new spinal cord implant that has successfully been trialed at Tel Aviv University in 15 paralyzed mice, 12 of which regained mobility.